What is the level of liabilities of Resmed this year?
Resmed has a debt balance of 2.62 B USD this year.
Resmed Liabilities 2024
Resmed Liabilities
2.62 B USD
Resmed Dividend yield
Ticker
RMD
ISIN
US7611521078
WKN
895878
In 2024, Resmed's total liabilities amounted to 2.62 B USD, a 51.1% difference from the 1.74 B USD total liabilities in the previous year.
Resmed Aktienanalyse
What does Resmed do?
ResMed Inc. is a global leading provider of medical devices for the treatment of sleep disorders and respiratory diseases. The company was founded in Australia by Peter Farrell, a former employee of the University of New South Wales, in 1989. Today, ResMed is headquartered in San Diego, California, and employs over 7,500 people worldwide. Business model: ResMed's business model is based on providing medical products and solutions for the treatment of sleep apnea and other respiratory diseases. The company develops and distributes masks, devices, and accessories that help patients breathe better and achieve restful sleep. ResMed also offers cloud-based software solutions and services to assist doctors and sleep labs in diagnosing and monitoring patients. Products and divisions: ResMed's product range can be divided into four main divisions: Sleep & Respiratory Care, Software as a Service (SaaS), Technologies, and Dental Solutions. Sleep & Respiratory Care: In this division, ResMed offers a wide range of masks, devices, and accessories for the treatment of sleep apnea and other respiratory diseases. The most well-known products include the AirSense and AirMini devices, equipped with Automatic Sleep Detection and AutoSet algorithm to optimize respiratory pressure. ResMed also offers a range of CPAP masks, nasal and full face masks, as well as nasal pillow masks. Software as a Service (SaaS): ResMed's cloud-based software solutions and services are offered under the brand AirView. They include diagnostic tools, patient monitoring systems, and analysis tools. AirView allows doctors to access their patients' medical data captured by ResMed devices and monitor this data in real-time. Technologies: ResMed's Technologies division focuses on the development of advanced sensors for respiratory and sleep monitoring. Products include the S+, a smart sleep tracking system that operates without direct body contact, and the Reveal-LTE, an implant for monitoring heart and respiratory rates in patients with heart failure. Dental Solutions: ResMed has also developed products for dentistry to assist patients with mild to moderate upper airway obstruction. Products include the Narval CC, a custom-made dental device for the treatment of snoring and sleep apnea, and the Tap Pap nasal pillow oral appliance, a non-invasive mouthguard. Conclusion: ResMed is a leading provider of medical devices and solutions for the treatment of sleep apnea and other respiratory diseases. The company offers innovative products and technologies that help patients breathe better and achieve restful sleep. ResMed's cloud-based software solutions enable doctors to monitor their patients' health in real-time and develop effective diagnosis and treatment strategies. With its wide range of products, innovation, and highly qualified team of scientists, engineers, and medical professionals, ResMed will continue to play an important role in the healthcare industry. Resmed ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Resmed's Liabilities
Resmed's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Resmed's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Resmed's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Resmed's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Resmed’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Resmed Stock
What were the liabilities of Resmed compared to the previous year?
The liabilities of Resmed have increased by 51.1% increased compared to the previous year.
What are the consequences of high debt for investors of Resmed?
High liabilities can pose a risk for investors of Resmed, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Resmed?
Low liabilities mean that Resmed has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Resmed affect the company?
An increase in liabilities of Resmed can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Resmed affect the company?
A decrease in the liabilities of Resmed can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Resmed?
Some factors that can influence the liabilities of Resmed include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Resmed so important for investors?
The liabilities of Resmed are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Resmed take to modify the liabilities?
To change its liabilities, Resmed can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Resmed pay?
Over the past 12 months, Resmed paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Resmed is expected to pay a dividend of 2.11 USD.
What is the dividend yield of Resmed?
The current dividend yield of Resmed is .
When does Resmed pay dividends?
Resmed pays a quarterly dividend. This is distributed in the months of June, September, December, March.
How secure is the dividend of Resmed?
Resmed paid dividends every year for the past 0 years.
What is the dividend of Resmed?
For the upcoming 12 months, dividends amounting to 2.11 USD are expected. This corresponds to a dividend yield of 0.97 %.
In which sector is Resmed located?
Resmed is assigned to the 'Health' sector.
Wann musste ich die Aktien von Resmed kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Resmed from 3/14/2024 amounting to 0.48 USD, you needed to have the stock in your portfolio before the ex-date on 2/7/2024.
When did Resmed pay the last dividend?
The last dividend was paid out on 3/14/2024.
What was the dividend of Resmed in the year 2023?
In the year 2023, Resmed distributed 1.72 USD as dividends.
In which currency does Resmed pay out the dividend?
The dividends of Resmed are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Resmed stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Resmed
Our stock analysis for Resmed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Resmed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
